REFERENCES
- Ginsburg H, Famin O, Zhang JM, Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 1998; 56: 1305–1313.
- Egan TJ. Structure-function relationships in chloroquine and related 4-aminoquinoline antimalarials. Mini Rev Med Chem 2001; 1: 113–123.
- Famin O, Krugliak M, Ginsburg H. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. Biochem Pharmacol 1999; 58: 59–68.
- Zhang J, Krugliak M, Ginsburg H. The fate of ferriprotoporphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs. Mol Biochem Parasitol 1998; 99: 129–141.
- Famin O, Ginsburg H. The treatment of Plasmodium falciparum- infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase. Parasite 2003; 10: 39–50.
- Dubois VL, Platel DFN, Pauly G, Tribouley-Duret J. Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Exp Parasitol 1995; 81: 117–124.
- Plate' DFN, Mangou F, Tribouley-Duret J. Role of glutathione in the detoxification of ferriprotoporphyrin IX in chloroquine resistant Plasmodium berghei. Mol Biochem Parasitol 1999; 98: 215–223.
- Harwaldt P, Rahlfs S, Becker K. Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target. Biol Chem 2002; 383: 821–830.
- Perez-Rosado J, Gervais GW, Ferrer R, Guez I, Peters W, Serrano AE. Plasmodium berghei: analysis of the gamma-glutamylcysteine synthetase gene in drug-resistant lines. Exp Parasitol 2002; 101: 175–182.
- Meierjohann S, Walter RD, Muller S. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine sensitive and chloroquine resistant Plasmodium falciparum. Biochem J 2002; 368: 761–768.
- Miller J, Golenser J, Spira DT, Kosover N. Thiol status and plasmodial growth in normal and G6PD deficient human erythrocytes. Exp Parasitol 1984; 57: 239–247.
- Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295–1302.
- Bahl A, Brunk B, Coppel RL et al. PlasmoDB: the Plasmodium genome resource. An integrated database providing tools for accessing, analyzing and mapping expression and sequence data (both finished and unfinished). Nucleic Acids Res 2002; 30: 87–90.
- Srivastava P, Puri SK, Kamboj KK, Pandey VC. Glutathione-S-transferase activity in malarial parasites. Trop Med Int Health 1999; 4: 251–254.
- Atamna H, Ginsburg H. The malaria parasite supplies glutathione to its host cell — investigation of glutathione transport and metabolism in human erythrocytes infected with Plasmodium falciparum. Eur J Biochem 1997; 250: 670–679.
- Cappellini MD, Tavazzi D, Duca L et al. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia. Br J Haematol 1999; 104: 504–512.
- Tavazzi D, Comino A, Turrini F, Fiorelli G, Cappellini MD. Indices of membrane alterations in beta-thalassemic erythrocytes. Hemoglobin 1998; 22: 483–492.
- Watt G, Jongsakul K, Ruangvirayuth R. A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. Q J Med 2002; 95: 285–290.
- Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels. Biochem Pharmacol 2003; 66: 809–817.
- Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AE Pghl modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000; 403: 906–909.
- Sidhu AB, Verdier-Pinard D, Fidock DA. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002; 298: 210–213.
- Davioud-Charvet E, Delarue S, Biot C et al. A prodrug form of a Plasmodium fakiparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J Med Chem 2001; 44: 4268–4276.
- Wolchok JD, Williams L, Pinto JT et al. Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma. Melanoma Res 2003; 13: 189–196.